Christopher P Kellner, MD
img_Christopher P Kellner
ASSOCIATE PROFESSOR | Neurosurgery
Are you a patient?
Specialties
Neurosurgery
Research Topics
Regeneration, Rehabilitation, Stem Cells, Stroke

MD, Columbia University College of Physicians & Surgeons

Residency, Neurosurgery, Columbia University Neurological Surgery

Certifications

American Board of Neurological Surgery
Recognition and Management of Acute Stroke
Visor Helps Determine If Someone Suffered Stroke

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kellner during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Von Medical
  • Borvo
  • Synchron
  • Aurenar
  • Radical
  • Borealis, Inc.
  • Metis Innovative, LLC
  • E8
  • Fluid Biomed
  • Reach Neuro
  • Precision Recovery Inc
  • Phantom Neuro
  • Proprio

Founder/Co-Founder/Partner

  • Borealis, Inc.
  • Metis Innovative, LLC
  • Precision Recovery Inc

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.